Skip to content
Trial Eligibility
Menu

Lupus Clinical Trials near Orange, CA

26 studies for Lupus are recruiting at 53 sites within 50 miles of Orange, California, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lupus trials in the US or all trials near Orange.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lupus studies enrolling near Orange

Showing 26 studies, nearest first.
  1. A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

    NCT06617325

    • Phase 3
    • Ages 16 years and older
    • Sex: All

    Nearest sites: Sl0044 50340 (Orange, CA); Sl0044 50275 (La Palma, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  2. VIBRANT: VIB4920 for Active Lupus Nephritis

    NCT05201469

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: of California, Irvine School of Medicine Division of Rheumatology (Orange, CA); UCLA Medical Center: Division of Rheumatology (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  3. RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

    NCT06121297

    • Phase 1/2
    • Ages 12 to 65 years
    • Sex: All

    Nearest site: University of California Irvine (Orange, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  4. A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

    NCT07438496

    • Phase 3
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Solace Clinical Research California (Tustin, CA); Providence Medical Foundation (Fullerton, CA)

    Distance to nearest recruiting site
    ~3 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  5. A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

    NCT06557265

    • Phase 1/2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Nkarta Investigational Site (Tustin, CA)

    Distance to nearest recruiting site
    ~3 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  6. A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

    NCT07607964

    • Phase 1
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Solace Research /ID# 279155 (Tustin, CA)

    Distance to nearest recruiting site
    ~3 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  7. A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

    NCT06308978

    • Phase 1
    • Ages 12 to 70 years
    • Sex: All

    Nearest sites: Providence Medical Foundation (Fullerton, CA); University of California Irvine (Irvine, CA)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  8. A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

    NCT07570862

    • Phase 2
    • Ages 12 to 70 years
    • Sex: All

    Nearest sites: Providence Medical Foundation (Fullerton, CA); University of California Irvine (Irvine, CA)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  9. Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

    NCT07201558

    • Phase 1
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: Research Site (Fullerton, CA)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. FT839 in Autoimmune Diseases

    NCT07800871

    • Phase 1/2
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Providence Medical Foundation (Fullerton, CA)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

    NCT07430306

    • Phase 3
    • Ages 18 to 70 years
    • Sex: All

    Nearest sites: Research Site (La Palma, CA); Research Site (Menifee, CA)

    Distance to nearest recruiting site
    ~12 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  12. Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

    NCT06133972

    • Phase 3
    • Ages 12 to 100 years
    • Sex: All

    Nearest sites: Advanced Medical Research (La Palma, CA); Providence Medical Center (Burbank, CA)

    Distance to nearest recruiting site
    ~12 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  13. A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

    NCT07409181

    • Phase 2
    • Ages 18 to 74 years
    • Sex: All

    Nearest sites: Arthritis & Osteoporosis Medical Center, Inc - La Palma (La Palma, CA); Inland Rheumatology Clinical Trials, Inc (Upland, CA)

    Distance to nearest recruiting site
    ~12 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  14. A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

    NCT06625671

    • Phase 1/2
    • Ages 18 to 70 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: US06-0 (La Palma, CA)

    Distance to nearest recruiting site
    ~12 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

    NCT07611214

    • Phase 4
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Valerius Medical Group & Research Center of Greater Long Beach, Inc. (Los Alamitos, CA)

    Distance to nearest recruiting site
    ~13 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study

    NCT05612750

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: SCAN Health Plan (Long Beach, CA)

    Distance to nearest recruiting site
    ~19 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA

    NCT07237659

    • Phase 1
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Covina Arthritis Clinic (Covina, CA); Novamed (Monterey Park, CA)

    Distance to nearest recruiting site
    ~21 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  18. A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

    NCT07355218

    • Phase 3
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Inland Rheumatology Clinical Trials, Inc. (Upland, CA)

    Distance to nearest recruiting site
    ~24 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

    NCT05799378

    • Phase 3
    • Ages 55 years and older
    • Sex: All

    Nearest site: University of California, Los Angeles (Los Angeles, CA)

    Distance to nearest recruiting site
    ~29 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

    NCT05835310

    • Phase 3
    • Ages 5 to 17 years
    • Sex: All

    Nearest site: Research Site (Los Angeles, CA)

    Distance to nearest recruiting site
    ~29 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

    NCT07332481

    • Phase 3
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Dermatology Research Associates - 300204025 (Los Angeles, CA)

    Distance to nearest recruiting site
    ~29 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

    NCT07691970

    • Phase 3
    • Ages 5 to 80 years
    • Sex: All

    Nearest site: Research Site (Los Angeles, CA)

    Distance to nearest recruiting site
    ~29 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. Lupus Landmark Study: A Prospective Registry and Biorepository

    NCT05934149

    • Observational
    • Ages 18 to 110 years
    • Sex: All

    Nearest site: Wallace Rheumatic Studies Center (Beverly Hills, CA)

    Distance to nearest recruiting site
    ~37 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

    NCT07260877

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: Investigative Site (Beverly Hills, CA)

    Distance to nearest recruiting site
    ~37 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

    NCT05039619

    • Phase 2
    • Ages 5 to 17 years
    • Sex: All

    Nearest site: Loma Linda University health (Loma Linda, CA)

    Distance to nearest recruiting site
    ~38 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

    NCT07085104

    • Phase 1
    • Ages 18 to 74 years
    • Sex: All

    Nearest site: Loma Linda University Medical Center (Loma Linda, CA)

    Distance to nearest recruiting site
    ~38 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lupus clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.